{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:49:28Z","timestamp":1792082968329,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsche Stiftung f\u00fcr junge Erwachsene mit Krebs"},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["377984878"],"award-info":[{"award-number":["377984878"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SU 1548\/1-1"],"award-info":[{"award-number":["SU 1548\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hertie Network of Excellence in Clinical Neuroscience"},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["Mildred Scheel Career Center Frankfurt"],"award-info":[{"award-number":["Mildred Scheel Career Center Frankfurt"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","award":["young investigator grant"],"award-info":[{"award-number":["young investigator grant"]}],"id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Central neurocytomas (CN) are intraventricular brain tumors predominantly occurring in young adults. Although prognosis is usually favorable, tumor recurrence is common, particularly following subtotal resection (STR). Currently, the risk of progression is evaluated using atypical features and an elevated Ki67 proliferation index. However, these markers lack consistent definitions, raising the need for objective criteria. Genome-wide DNA methylation profiles were examined in 136 tumors histologically classified as CN. Clinical\/histopathological characteristics were assessed in 93\/90 cases, and whole-exome sequencing was conducted in 12 cases. Clinical and molecular characteristics were integrated into a survival model to predict progression-free survival (PFS). A diagnosis of CN was epigenetically confirmed in 125 of 136 cases (92%). No DNA methylation subgroups were identified, but global DNA hypomethylation emerged as a hallmark feature of CN associated with higher recurrence risk. Risk stratification based on histological features of atypia and Ki67 proliferation index was not reproducible across neuropathologists. Hypomethylation at the\n                    <jats:italic>FGFR3<\/jats:italic>\n                    locus, accompanied by increased FGFR3 protein expression, was observed in 97% of cases. Gross total resection was associated with significantly improved PFS compared to STR, while patients undergoing STR receiving radiotherapy had a better outcome (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0001). Younger patients were identified as having a higher risk of recurrence (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.026). Patient age and treatment strategy were key factors associated with survival outcomes in this cohort. These findings underscore the importance of closer follow-up for younger patients and radiotherapy for STR cases. Furthermore,\n                    <jats:italic>FGFR3<\/jats:italic>\n                    represents a hallmark feature and potential therapeutic target, warranting further investigation.\n                  <\/jats:p>","DOI":"10.1007\/s00401-025-02894-3","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T08:09:14Z","timestamp":1749629354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Outcome-associated factors in a molecularly defined cohort of central neurocytoma"],"prefix":"10.1007","volume":"149","author":[{"given":"Maja","family":"Krech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Muench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Teichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kuzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail K.","family":"Suwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska M.","family":"Ippen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"M\u00fcther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina J.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Wenger-Alakmeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Onken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vajkoczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Behling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Axel","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Ntoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim K.","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oday","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Esmaeilzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf C.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.","family":"Heppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Radbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Dittmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Capper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl H.","family":"Plate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim P.","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Czabanka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi","family":"Beschorner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"von Deimling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bockmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Brandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonille","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"2894_CR1","unstructured":"WHO Classification of Tumours Editorial Board (2021) Central nervous system tumours. International Agency for Research on Cancer, City"},{"key":"2894_CR2","doi-asserted-by":"publisher","first-page":"P141","DOI":"10.1158\/1535-7163.Targ-21-p141","volume":"20","author":"JA Ballard","year":"2021","unstructured":"Ballard JA, Kercher T, Abraham D, Brecht R, Brooks NA, Buckles T et al (2021) Abstract P141: Preclinical characterization of LOX-24350, a highly potent and isoform-selective FGFR3 inhibitor. Mol Cancer Ther 20:P141\u2013P141. https:\/\/doi.org\/10.1158\/1535-7163.Targ-21-p141","journal-title":"Mol Cancer Ther"},{"key":"2894_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/(sici)1097-0142(20000101)88:1<169::aid-cncr23>3.0.co;2-7","volume":"88","author":"AA Brandes","year":"2000","unstructured":"Brandes AA, Amist\u00e0 P, Gardiman M, Volpin L, Danieli D, Guglielmi B et al (2000) Chemotherapy in patients with recurrent and progressive central neurocytoma. Cancer 88:169\u2013174. https:\/\/doi.org\/10.1002\/(sici)1097-0142(20000101)88:1%3c169::aid-cncr23%3e3.0.co;2-7","journal-title":"Cancer"},{"key":"2894_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11060-018-2997-z","volume":"140","author":"J Byun","year":"2018","unstructured":"Byun J, Hong SH, Yoon MJ, Kwon SM, Cho YH, Kim JH et al (2018) Prognosis and treatment outcomes of central neurocytomas: clinical interrogation based on a single center experience. J Neurooncol 140:669\u2013677. https:\/\/doi.org\/10.1007\/s11060-018-2997-z","journal-title":"J Neurooncol"},{"key":"2894_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469\u2013474. https:\/\/doi.org\/10.1038\/nature26000","journal-title":"Nature"},{"key":"2894_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","volume":"136","author":"D Capper","year":"2018","unstructured":"Capper D, Stichel D, Sahm F, Jones DTW, Schrimpf D, Sill M et al (2018) Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol 136:181\u2013210. https:\/\/doi.org\/10.1007\/s00401-018-1879-y","journal-title":"Acta Neuropathol"},{"key":"2894_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13014-014-0242-2","volume":"9","author":"YD Chen","year":"2014","unstructured":"Chen YD, Li WB, Feng J, Qiu XG (2014) Long-term outcomes of adjuvant radiotherapy after surgical resection of central neurocytoma. Radiat Oncol 9:242. https:\/\/doi.org\/10.1186\/s13014-014-0242-2","journal-title":"Radiat Oncol"},{"key":"2894_CR8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/ede.0000000000001630","volume":"34","author":"R Denz","year":"2023","unstructured":"Denz R, Timmesfeld N (2023) Visualizing the (Causal) effect of a continuous variable on a time-to-event outcome. Epidemiology 34:652\u2013660. https:\/\/doi.org\/10.1097\/ede.0000000000001630","journal-title":"Epidemiology"},{"key":"2894_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/neuonc\/noad197","volume":"26","author":"A Eckhardt","year":"2024","unstructured":"Eckhardt A, Drexler R, Schoof M, Struve N, Capper D, Jelgersma C et al (2024) Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma. Neuro Oncol 26:503\u2013513. https:\/\/doi.org\/10.1093\/neuonc\/noad197","journal-title":"Neuro Oncol"},{"key":"2894_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3171\/jns.1997.86.3.0547","volume":"86","author":"DY Eng","year":"1997","unstructured":"Eng DY, DeMonte F, Ginsberg L, Fuller GN, Jaeckle K (1997) Craniospinal dissemination of central neurocytoma. Report Two Cases J Neurosurg 86:547\u2013552. https:\/\/doi.org\/10.3171\/jns.1997.86.3.0547","journal-title":"Report Two Cases J Neurosurg"},{"key":"2894_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/bioinformatics\/btw691","volume":"33","author":"JP Fortin","year":"2017","unstructured":"Fortin JP, Triche TJ Jr, Hansen KD (2017) Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics 33:558\u2013560. https:\/\/doi.org\/10.1093\/bioinformatics\/btw691","journal-title":"Bioinformatics"},{"key":"2894_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515\u2013526. https:\/\/doi.org\/10.1093\/biomet\/81.3.515","journal-title":"Biometrika"},{"key":"2894_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1146","volume":"49","author":"Z Gu","year":"2021","unstructured":"Gu Z, Schlesner M, H\u00fcbschmann D (2021) cola: an R\/Bioconductor package for consensus partitioning through a general framework. Nucleic Acids Res 49:e15. https:\/\/doi.org\/10.1093\/nar\/gkaa1146","journal-title":"Nucleic Acids Res"},{"key":"2894_CR14","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath S (2013) DNA methylation age of human tissues and cell types. Genome Biol 14:R115. https:\/\/doi.org\/10.1186\/gb-2013-14-10-r115","journal-title":"Genome Biol"},{"key":"2894_CR15","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.18632\/aging.101508","volume":"10","author":"S Horvath","year":"2018","unstructured":"Horvath S, Oshima J, Martin GM, Lu AT, Quach A, Cohen H et al (2018) Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies. Aging (Albany NY) 10:1758\u20131775. https:\/\/doi.org\/10.18632\/aging.101508","journal-title":"Aging (Albany NY)"},{"key":"2894_CR16","doi-asserted-by":"publisher","first-page":"16737","DOI":"10.1021\/acs.jmedchem.4c01531","volume":"67","author":"RL Hudkins","year":"2024","unstructured":"Hudkins RL, Allen E, Balcer A, Hoffman ID, Iyer S, Neal M et al (2024) Discovery of TYRA-300: first oral selective FGFR3 inhibitor for the treatment of urothelial cancers and achondroplasia. J Med Chem 67:16737\u201316756. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c01531","journal-title":"J Med Chem"},{"key":"2894_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11060-015-1959-y","volume":"126","author":"BS Imber","year":"2016","unstructured":"Imber BS, Braunstein SE, Wu FY, Nabavizadeh N, Boehling N, Weinberg VK et al (2016) Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience. J Neurooncol 126:193\u2013200. https:\/\/doi.org\/10.1007\/s11060-015-1959-y","journal-title":"J Neurooncol"},{"key":"2894_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1158\/1538-7445.Am2023-ct119","volume":"83","author":"G Iyer","year":"2023","unstructured":"Iyer G, Siefker-Radtke A, Milowsky M, Shore N, Gao X, Reimers MA et al (2023) Abstract CT119: A first-in-human phase 1 study of LOXO-435, a potent, highly isoform-selective FGFR3 inhibitor in advanced solid tumors with FGFR3 alterations (trial in progress). Cancer Res 83:119\u2013119. https:\/\/doi.org\/10.1158\/1538-7445.Am2023-ct119","journal-title":"Cancer Res"},{"key":"2894_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2217\/cns-2019-0012","volume":"8","author":"MO Johnson","year":"2019","unstructured":"Johnson MO, Kirkpatrick JP, Patel MP, Desjardins A, Randazzo DM, Friedman HS et al (2019) The role of chemotherapy in the treatment of central neurocytoma. CNS Oncol 8:41. https:\/\/doi.org\/10.2217\/cns-2019-0012","journal-title":"CNS Oncol"},{"key":"2894_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41571-024-00869-z","volume":"21","author":"M Katoh","year":"2024","unstructured":"Katoh M, Loriot Y, Brandi G, Tavolari S, Wainberg ZA, Katoh M (2024) FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions. Nat Rev Clin Oncol 21:312\u2013329. https:\/\/doi.org\/10.1038\/s41571-024-00869-z","journal-title":"Nat Rev Clin Oncol"},{"key":"2894_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/genes8060152","author":"A Kozlenkov","year":"2017","unstructured":"Kozlenkov A, Jaffe AE, Timashpolsky A, Apontes P, Rudchenko S, Barbu M et al (2017) DNA methylation profiling of human prefrontal cortex neurons in heroin users shows significant difference between genomic contexts of hyper- and hypomethylation and a younger epigenetic age. Genes (Basel). https:\/\/doi.org\/10.3390\/genes8060152","journal-title":"Genes (Basel)"},{"key":"2894_CR22","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/s12276-024-01204-3","volume":"56","author":"Y Lee","year":"2024","unstructured":"Lee Y, Chowdhury T, Kim S, Yu HJ, Kim KM, Kang H et al (2024) Central neurocytoma exhibits radial glial cell signatures with FGFR3 hypomethylation and overexpression. Exp Mol Med 56:975\u2013986. https:\/\/doi.org\/10.1038\/s12276-024-01204-3","journal-title":"Exp Mol Med"},{"key":"2894_CR23","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/neuonc\/noy003","volume":"20","author":"P Liao","year":"2018","unstructured":"Liao P, Ostrom QT, Stetson L, Barnholtz-Sloan JS (2018) Models of epigenetic age capture patterns of DNA methylation in glioma associated with molecular subtype, survival, and recurrence. Neuro Oncol 20:942\u2013953. https:\/\/doi.org\/10.1093\/neuonc\/noy003","journal-title":"Neuro Oncol"},{"key":"2894_CR24","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1097\/pas.0000000000002118","volume":"47","author":"A Muench","year":"2023","unstructured":"Muench A, Teichmann D, Spille D, Kuzman P, Perez E, May SA et al (2023) A novel type of IDH-wildtype glioma characterized by gliomatosis cerebri-like growth pattern, TERT promoter mutation, and distinct epigenetic profile. Am J Surg Pathol 47:1364\u20131375. https:\/\/doi.org\/10.1097\/pas.0000000000002118","journal-title":"Am J Surg Pathol"},{"key":"2894_CR25","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.clinimag.2016.06.004","volume":"40","author":"M Nayyar","year":"2016","unstructured":"Nayyar M, Mayo MC, Shiroishi M, Commins D, Liu CY, Go JL et al (2016) Atypical central neurocytoma with metastatic craniospinal dissemination: a case report. Clin Imaging 40:1108\u20131111. https:\/\/doi.org\/10.1016\/j.clinimag.2016.06.004","journal-title":"Clin Imaging"},{"key":"2894_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12766","volume":"48","author":"JAR Nicoll","year":"2022","unstructured":"Nicoll JAR, Bloom T, Clarke A, Boche D, Hilton D (2022) BRAIN UK: Accessing NHS tissue archives for neuroscience research. Neuropathol Appl Neurobiol 48:e12766. https:\/\/doi.org\/10.1111\/nan.12766","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2894_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11060-008-9622-5","volume":"90","author":"SH Paek","year":"2008","unstructured":"Paek SH, Han JH, Kim JW, Park CK, Jung HW, Park SH et al (2008) Long-term outcome of conventional radiation therapy for central neurocytoma. J Neurooncol 90:25\u201330. https:\/\/doi.org\/10.1007\/s11060-008-9622-5","journal-title":"J Neurooncol"},{"key":"2894_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00401-023-02674-x","volume":"147","author":"LC Pohl","year":"2024","unstructured":"Pohl LC, Leitheiser M, Obrecht D, Schweizer L, Wefers AK, Eckhardt A et al (2024) Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomas. Acta Neuropathol 147:24. https:\/\/doi.org\/10.1007\/s00401-023-02674-x","journal-title":"Acta Neuropathol"},{"key":"2894_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11060-005-9047-3","volume":"77","author":"D Rades","year":"2006","unstructured":"Rades D, Schild SE (2006) Treatment recommendations for the various subgroups of neurocytomas. J Neurooncol 77:305\u2013309. https:\/\/doi.org\/10.1007\/s11060-005-9047-3","journal-title":"J Neurooncol"},{"key":"2894_CR30","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1212\/01.wnl.0000115392.21898.e3","volume":"62","author":"D Rades","year":"2004","unstructured":"Rades D, Schild SE, Fehlauer F (2004) Prognostic value of the MIB-1 labeling index for central neurocytomas. Neurology 62:987\u2013989. https:\/\/doi.org\/10.1212\/01.wnl.0000115392.21898.e3","journal-title":"Neurology"},{"key":"2894_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/sim.2331","volume":"25","author":"P Royston","year":"2006","unstructured":"Royston P, Altman DG, Sauerbrei W (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25:127\u2013141. https:\/\/doi.org\/10.1002\/sim.2331","journal-title":"Stat Med"},{"key":"2894_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/s1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18:682\u2013694. https:\/\/doi.org\/10.1016\/s1470-2045(17)30155-9","journal-title":"Lancet Oncol"},{"key":"2894_CR33","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1093\/brain\/awaa334","volume":"143","author":"GL Shireby","year":"2020","unstructured":"Shireby GL, Davies JP, Francis PT, Burrage J, Walker EM, Neilson GWA et al (2020) Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex. Brain 143:3763\u20133775. https:\/\/doi.org\/10.1093\/brain\/awaa334","journal-title":"Brain"},{"key":"2894_CR34","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/00005072-199705000-00011","volume":"56","author":"F S\u00f6ylemezoglu","year":"1997","unstructured":"S\u00f6ylemezoglu F, Scheithauer BW, Esteve J, Kleihues P (1997) Atypical central neurocytoma. J Neuropathol Exp Neurol 56:551\u2013556. https:\/\/doi.org\/10.1097\/00005072-199705000-00011","journal-title":"J Neuropathol Exp Neurol"},{"key":"2894_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1023\/a:1022553110232","volume":"61","author":"H Takao","year":"2003","unstructured":"Takao H, Nakagawa K, Ohtomo K (2003) Central neurocytoma with craniospinal dissemination. J Neurooncol 61:255\u2013259. https:\/\/doi.org\/10.1023\/a:1022553110232","journal-title":"J Neurooncol"},{"key":"2894_CR36","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/neuonc\/noaa267","volume":"23","author":"C Thomas","year":"2021","unstructured":"Thomas C, Soschinski P, Zwaig M, Oikonomopoulos S, Okonechnikov K, Pajtler KW et al (2021) The genetic landscape of choroid plexus tumors in children and adults. Neuro Oncol 23:650\u2013660. https:\/\/doi.org\/10.1093\/neuonc\/noaa267","journal-title":"Neuro Oncol"},{"key":"2894_CR37","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00401-021-02300-8","volume":"141","author":"C Thomas","year":"2021","unstructured":"Thomas C, Thierfelder F, Tr\u00e4ger M, Soschinski P, M\u00fcther M, Edelmann D et al (2021) TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma. Acta Neuropathol 141:959\u2013970. https:\/\/doi.org\/10.1007\/s00401-021-02300-8","journal-title":"Acta Neuropathol"},{"key":"2894_CR38","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/neuonc\/noad030","volume":"25","author":"M Tr\u00e4ger","year":"2023","unstructured":"Tr\u00e4ger M, Schweizer L, P\u00e9rez E, Schmid S, Hain EG, Dittmayer C et al (2023) Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatment. Neuro Oncol 25:1286\u20131298. https:\/\/doi.org\/10.1093\/neuonc\/noad030","journal-title":"Neuro Oncol"},{"key":"2894_CR39","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/PAS.0b013e31823b8232","volume":"36","author":"A Vasiljevic","year":"2012","unstructured":"Vasiljevic A, Fran\u00e7ois P, Loundou A, F\u00e8vre-Montange M, Jouvet A, Roche PH et al (2012) Prognostic factors in central neurocytomas: a multicenter study of 71 cases. Am J Surg Pathol 36:220\u2013227. https:\/\/doi.org\/10.1097\/PAS.0b013e31823b8232","journal-title":"Am J Surg Pathol"},{"key":"2894_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13083","volume":"32","author":"N Woltering","year":"2022","unstructured":"Woltering N, Albers A, M\u00fcther M, Stummer W, Paulus W, Hasselblatt M et al (2022) DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups. Brain Pathol 32:e13083. https:\/\/doi.org\/10.1111\/bpa.13083","journal-title":"Brain Pathol"},{"key":"2894_CR41","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1158\/0008-5472.Can-23-3195","volume":"84","author":"Y Yang","year":"2024","unstructured":"Yang Y, Suhasini AN, Jiang Z, Liu N, Rosconi M, Zhang B et al (2024) A tetravalent bispecific antibody selectively inhibits diverse FGFR3 oncogenic variants. Can Res 84:2169\u20132180. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-3195","journal-title":"Can Res"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02894-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-025-02894-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02894-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T08:09:16Z","timestamp":1749629356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-025-02894-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2894"],"URL":"https:\/\/doi.org\/10.1007\/s00401-025-02894-3","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DC and AvD are co-founders and shareholders of Heidelberg Epignostix GmbH.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"61"}}